3:55 1. The CAPE-40 gate — a base rate you check before you forecast
The repeatable method
- Value a whole market, not a stock: take the CAPE ratio — price against ten years of inflation-adjusted earnings — so one boom or bust year can't set the number.
- Ask a historical question rather than a predictive one: across every country-year on record, when a market closed a year above a given CAPE, what were the subsequent 10-year real returns? Count the hit rate, don't model it.
- Treat the answer as gravity, not a trigger. Explicitly refuse the timing claim — "there's no ceiling on valuation… it could easily go up to 50 or 60," and Japan did — so the output is position tilt and expectation-setting, not an exit.
- Set a review date and commit to being scored on it, so the claim is falsifiable.
Here: Shiller CAPE ~44 and about to eclipse 1999's "44 and change" — "never once in history have we found a market that closed a year, a country, at a CAPE ratio of 40 and had above average 10-year real returns… the batting average is pretty low, zero," with the honest qualifier that many were still "okay." Verdict: "yellow light. Expensive market going up." Scoring date: end of 2036.
Watch for
- Year-end closing CAPE for the market you own (the base rate is on year-closes, not intraday highs); the appearance of genuine competing yields ("old-school bonds. Pretty good yield") that give the tilt somewhere to go.
4:47 2. Audit the index for hidden concentration — cap weighting is a bet
The repeatable method
- Treat "just buy the market" as an active decision with a known bias: weights follow price, so the index automatically holds most of whatever has risen most.
- Test where that bias bites: it is harmless in a broad, cheap market; it is dangerous in small national markets, single sectors, and any cap-weighted boom.
- Cross the concentration read with the valuation read — the biggest weights and the most expensive names are usually the same names, so cap weighting maximises your exposure exactly where the base rate is worst.
- If the diagnosis holds, fix it by changing the weighting scheme (equal or fundamental weight) rather than by leaving equities.
Here: "You concentrate in the things that have gone up the most, which usually are the things that are also the most expensive… this is true certainly in the US and getting more so by the day," with Rob Arnott's summary that cap weighting means you "buy high and sell low" — the stated design premise of GEX.
Watch for
- Top-10 index weight as a share of the whole; whether your "diversified" fund's largest positions are also its highest-multiple ones.
7:21 3. The 351 exchange — the arithmetic test before the tax conversation
The repeatable method
- Identify the actual problem: a concentrated, heavily-appreciated position the holder won't sell because of the tax, not because they still believe in it. Both conventional exits are bad — hold and carry single-stock risk, or sell and realise the gain.
- Run the eligibility arithmetic in your head first, because it is only two numbers: no contributed position above 25%, and the top five under 50%. That implies roughly 11–12 positions. Broad index ETFs are pass-through, so a fund like SPY is looked through to its underlying holdings and can do much of the diversifying work.
- Screen the assets for admissibility: liquid listed stocks and ETFs only. Excluded — microcaps, foreign stocks into a US fund, hedge/mutual funds, derivatives, options, futures, crypto, leveraged and covered-call ETFs.
- Check strategy fit: the contributed portfolio "should roughly match the fund prospectus and strategy" being launched.
- Price the deferral honestly. This is not forgiveness — contributed basis carries through, and if the fund compounds, "the tax liability will actually be bigger. It's just delayed."
- Test whether the holder even wants the deferral: a young, low-income holder may be better off gain-harvesting now; an older holder donating stock or relying on a step-up may not need it at all.
- Confirm the plumbing before promising anything — custodian support is the binding constraint, not the tax code.
Here: the November GEX seeding, contributions due within a month, at 25bp; Schwab has "a whole 351 department" and an account minimum potentially as low as $150k, Fidelity "won't do it," wirehouses are hard; Cambria asks ~$5M per advisor relationship and runs a portfolio-qualification tool. ~$20bn done in 351s, hundreds of billions including mutual-fund and hedge-fund conversions.
Watch for
- Treasury/IRS clarification of the rules — he explicitly wants it, because clear rules would open Merrill and Morgan and push out bad actors; custodian policy changes (Fidelity building its own and blocking third parties is his stated expectation).
26:41 4. The tax-tail test — would you own the strategy with no tax benefit at all?
The repeatable method
- Before accepting any tax-motivated structure, strip the tax benefit out and ask whether you would buy the underlying strategy on its merits. If the answer is no, the tax tail is wagging the dog.
- Diligence the sponsor with a behavioural tell rather than a document: watch the portfolio's turnover immediately after the seeding. A manager who reconstitutes the contributed portfolio on day one has revealed that the tax event was the entire product.
- Prefer sponsors who accept constraints that cost them assets (rejecting microcaps, derivatives, mismatched strategies) over those who accept everything.
Here: "You'll see some firms launch a portfolio and turn it over on day one, which makes it look as if the only reason they were doing this was tax related. And to me that's not thoughtful. You should want to invest in the strategy no matter what."
Watch for
- Post-seeding turnover and holdings disclosure (Cambria publishes holdings daily — so the test is runnable on his own funds); regulatory attention as a filter that removes the aggressive operators.
46:34 5. The net-issuance audit — the single number most income screens omit
The repeatable method
- Add up all cash returned to owners, not just the dividend: dividends + net buybacks + debt paydown. That total is "shareholder yield."
- Make the buyback figure net. Take announced or executed repurchases and subtract shares issued — above all stock-based compensation. Gross buyback numbers are close to meaningless on their own.
- Run the subtraction explicitly: a 5% announced buyback against 7% a year of stock handed to the C-suite is a negative buyback yield — the company is a net issuer diluting you.
- Apply the same correction to any income holding: a 3% dividend yielder issuing 5% of its shares a year is a negative-yielding stock however good the headline looks.
- Sanity-check the base rate: "the average stock in the US is an issuer," so assume dilution until you've checked.
Here: "You may see, 'Oh, this company announced 5% buyback.' Well, wait, they also give the C-suite 7% a year in shares and stock-based compensation, so it's actually negative buyback yield, meaning share issuance." The claimed payoff is the shareholder-yield trio (SYLD/FYLD/EYLD) sitting top-decile over ten years.
Watch for
- Diluted share count trending up while buybacks are announced; SBC as a percentage of shares outstanding; any dividend fund's methodology document — if the word "buyback" doesn't appear, the screen is incomplete by construction.
46:01 6. Every factor has an avoidance half — sell the expensive, not just buy the cheap
The repeatable method
- For any factor you use, write down both halves. Value isn't only "buy cheap companies" — it is equally "avoid the companies trading at a thousand times revenue."
- Apply the same symmetry to cash return: buying the net repurchasers matters less than systematically excluding the serial issuers, historically "a pretty terrible place to invest."
- Build the exclusion into the screen's construction rather than leaving it to judgement — the avoidance leg is what a naive one-sided screen quietly gives away.
Here: "Much like value, if you're Warren Buffett, you want to buy cheap companies, but it's also you want to avoid the expensive… It's not just you're buying the cheap stocks doing buybacks. It's also you're avoiding the opposite."
Watch for
- Screens that rank only on the desirable end (highest yield, cheapest multiple) with no exclusion rule at the other end.
16:37 7. Dividend drag — decide by account type before you decide by strategy
The repeatable method
- Ask what the money is for. If the objective is compounding rather than spending, a forced distribution is a mandatory taxable event you did not choose.
- Trace the round trip on the cash: money leaves the company, is taxed on receipt, and only the remainder gets reinvested. Nothing about the underlying business changed.
- Prefer companies that retain or repurchase over those that distribute — for the taxable account only. In a tax-sheltered account the whole argument disappears.
- Size the effect against the right benchmark. Versus a ~1% index yield the drag is small; the meaningful comparison is against the historically 6–10% high-dividend strategies.
- Compare on an after-tax basis: a low-dividend portfolio only has to roughly match the index pre-tax to beat it after tax.
Here: TAX — "if you're a taxable investor whose focus is compounding, the last thing in the world you want is dividends"; the S&P's all-time-low 1.04% yield makes the index a weak comparison, so "it's really targeting the high dividend strategies."
Watch for
- Which account the holding sits in (taxable vs sheltered) before judging any income strategy; index dividend yield as the measure of how much the drag currently matters.
43:35 8. Country-level value — rotate markets, not stocks
The repeatable method
- Move the value decision up a level: rank the ~45 investable country markets rather than screening individual companies bottom-up.
- Rank on multiple long-run metrics — CAPE plus cash flow, dividends and book — then average them. They "usually almost all say the same thing," so disagreement between them is itself information.
- Take the cheapest third-to-quarter (about 12–15 countries), knowing a country typically only gets there after falling 50–80%, and expect a mix of developed and emerging.
- Populate each country from its own large-cap set — e.g. the top 10 stocks out of the top 30 by market cap — accepting that this lands you somewhere different from bottom-up selection, especially in small markets with few listings.
- Rebalance once a year and tolerate years with no trades at all; publish the inputs so the process can be checked.
- Underwrite the holding period honestly: expect long stretches of underperformance while an expensive market keeps winning.
Here: GVAL — cheapest countries at "high single digit, low double digit CAPE ratios. Remember the US is 42 today"; launched 2014 and "for the first what 6 years foreign just sucked it up versus the US"; quarterly valuation metrics published on the Idea Farm.
Watch for
- The country-CAPE spread versus the US (the wider it is, the bigger the prospective rotation); listing depth in each cheap market, which determines whether a top-down basket even resembles the country's economy.
36:13 9. LEGO construction — substitute sleeves, don't bolt on satellites
The repeatable method
- Map the portfolio by sleeve first — US equity, foreign equity, emerging equity, fixed income, real assets — not by product.
- Improve a sleeve by replacing it with a better-constructed version of the same exposure, so the asset allocation is untouched and only the weighting rule changes. Swapping a plain US fund for a shareholder-yield fund is a substitution, not a new bet.
- Keep genuinely different exposures as small satellites, and label them as such: deep value, hedged equity, tail risk.
- Distinguish core sleeves along one axis — always-invested (buy-and-hold) versus conditionally-invested (trend, which can go entirely to cash) — and consider holding both, since each fails in the environment where the other works.
Here: "They're like LEGO building blocks. I take out my US equities, I put in SYLD or EYLD for emerging equities — those are very simple substitutions." Core: GAA (buy-hold) ↔ GMOM (trend), combined half-and-half in TRTY; satellites: GVAL, VAMO (50% hedged today), TAIL.
Watch for
- Whether a "new idea" changes your asset allocation or only the weighting inside a sleeve — the second is far cheaper to be wrong about.
37:51 10. The four-question allocation audit
The repeatable method
- Home bias: is it all US stocks and bonds with no foreign exposure at all?
- Weighting: is every equity sleeve market-cap weighted, with no tilt to value, mid or small?
- Real assets: is there any exposure to commodities, commodity equities, TIPS or global REITs — the things that hold up if "all roads lead to inflation"?
- Conditional exposure: is there any trend/managed-futures sleeve that can actually step aside, or is the whole portfolio permanently long?
- Note that he applies this to institutions and professionals as well as retail — the failure is not a retail failure.
Here: "The main mistakes… A, they put all their money in US only. B, it's market cap weighted, so they don't tilt to value or mid or small, which I think you should, especially right now. They don't own any real assets" — with BLDG offered for the third and trend following named as the fourth, "where I'm probably the most afield."
Watch for
- TIPS pricing (he flags they "look pretty good now"); global REIT returns; whether ex-US outperformance persists long enough for the home-biased to notice.
32:32 11. Price every bond sleeve against T-bills — and let the spread decide
The repeatable method
- Set the risk-free T-bill yield as the hurdle, then ask what each riskier sleeve — corporates, high yield, long duration — pays above it.
- Move out the risk curve only when the spread genuinely compensates; when it doesn't, staying in bills is a position, not indecision.
- Run a second, independent read on the same sleeves — trend — and treat agreement between the value and trend signals as confirmation. When the two barely overlap, that itself is the message.
- Hold the contrarian possibility explicitly: rates going higher from here would surprise most positioning, so don't reach for yield in a way that only works if they fall.
Here: "There's just not enough yield in these fixed income markets" relative to T-bills, so TYLD (trend) and its value sibling currently have "not a whole lot of overlap"; and "it feels like rates could and should go higher, which I think would surprise a lot of people."
Watch for
- Credit spreads — he explicitly wants the "razor thin" corporate/junk spreads to blow out before launching insurance against them; the T-bill-to-corporate gap as the trigger to extend risk.
0:39 12. Presidential-cycle seasonality — a calendar tilt, not a timing signal
The repeatable method
- Overlay the four-year presidential cycle on the 12-month calendar and look at the market and small caps separately — the two have different seasonal profiles.
- Identify the strongest six- and twelve-month windows within the cycle and use them as a tilt on timing decisions you were going to make anyway (when to deploy new money, when to rebalance), not as an in-out switch.
- Hold it loosely and say so — "we'll see if it remains true" — because a seasonal edge is a base rate, not a forecast.
Here: "We're about to enter the best 12-month period… starting in like October," and within the whole cycle "the biggest month of returns for small cap and small cap value is in January" — stated alongside two years of unnoticed small/value/ex-US outperformance.
Watch for
- Whether the October-onward window and the January small-cap-value effect show up this cycle; the general point that the tilt and the valuation read (cheap small/value, expensive large-cap US) currently point the same way.
Methods distilled from the public YouTube video / webinar recording (transcript in transcript.txt). The appearance was a sales webinar by the manager of the funds discussed — the methods are reusable, the product conclusions are promotional. Not investment advice.